[{"Assets_0_Q1_USD":1228300000.0,"CIK":"899923","CommonStockSharesConverted_0_Q1_shares":69200000.0,"CommonStockSharesOutstanding_0_Q1_shares":69200000.0,"Country":"United States","EarningsPerShareBasic_1_Q1_USD":1.18,"EarningsPerShareDiluted_1_Q1_USD":1.15,"Industry":"Biotechnology: In Vitro & In Vivo Diagnostic Substances","Market":"NASDAQ","Market Cap":"1850258412.0","NetCashProvidedByUsedInOperatingActivitiesConverted_1_Q1_USD":23500000.0,"NetIncomeLossConverted_1_Q1_USD":81100000.0,"OfficialName":"Myriad Genetics Inc. Common Stock","RevenuesConverted_1_Q1_USD":190200000.0,"SP500":"nan","Sector":"Health Care","StockholdersEquityConverted_0_Q1_USD":870600000.0,"StockholdersEquity_0_Q1_USD":870900000.0,"Ticker":"MYGN","WeightedAverageNumberOfDilutedSharesOutstanding_1_Q1_shares":70400000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q1_shares":68600000.0,"filed":"20171108","footnote":"nan","form":"10-Q","fp":"Q1","fy":"2018.0","name":"MYRIAD GENETICS INC","period":"20170930","qtrs":"0","uom":"USD"}]